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Lymphedema is a debilitating and disfiguring sequela of an overwhelmed lymphatic system.
The most common causes of secondary lymphedema are lymphatic filariasis (LF), a vector-
borne, parasitic disease endemic in 73 tropical countries, and treatment for cancer in devel-
oped countries. Lymphedema is incurable and requires life-long care so identification of
effective lymphedema management is imperative to improve quality of life, reduce the bur-
den on family resources and benefit the local community. This review was conducted to
evaluate the evidence for effective lymphedema self-care strategies that might be applica-
ble to management of all types of secondary lymphedema.
Methodology/Principal Findings
Searches were conducted in Medline, CINAHL and Scopus databases in March 2015.
Included studies reported before and after measures of lymphedema status or frequency of
acute infections. The methodological quality was assessed using the appropriate Critical
Appraisal Skills Program checklist. Descriptive synthesis and meta-analysis were used to
evaluate effectiveness of the outcomes reported. Twenty-eight papers were included; two
RCTs were found to have strong methodology, and overall 57% of studies were rated as
methodologically weak. Evidence from filariasis-related lymphedema (FR-LE) studies indi-
cated that hygiene-centred self-care reduced the frequency and duration of acute episodes
by 54%, and in cancer-related lymphedema (CR-LE) home-based exercise including deep
breathing delivered significant volume reductions over standard self-care alone. Intensity of
training in self-care practices and frequency of monitoring improved outcomes. Cultural and
economic factors and access to health care services influenced the type of intervention
delivered and how outcomes were measured.
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Conclusions/Significance
There is evidence to support the adoption of remedial exercises in the management of FR-
LE and for a greater emphasis on self-treatment practices for people with CR-LE. Empower-
ment of people with lymphedema to care for themselves with access to supportive profes-
sional assistance has the capacity to optimise self-management practices and improve
outcomes from limited health resources.
Author Summary
Secondary lymphedema is a major cause of disability worldwide. The most common
causes are treatment for cancer or infection with lymphatic filariasis. In both cases, the
lymphatic system is damaged and unable to perform its normal function of removing
extracellular fluid and wastes. Protein rich fluid accumulates in the affected area, and if left
untreated may progress to ‘elephantiasis’, which is characterised by a grossly enlarged limb
and thickening of the skin. Lymphedema is incurable, requires lifelong care, and psychoso-
cial support, but early intervention and good self-management practices can halt progres-
sion, preserve quality of life and maintain the ability to participate in normal work and
social activities. Current approaches to treatment vary depending on the setting. In devel-
oped countries, cancer related lymphoedema is therapist-based and aims to intervene
early and prevent disease progression. Lymphatic filariasis related lymphedema is associ-
ated with poverty, affecting people living in developing countries where minimal interven-
tion is recommended or available for early stages. By identifying useful practices that can
be transferred across cultural and economic borders, people living with lymphedema can
be empowered to care for themselves and improve their long term outcomes.
Introduction
Lymphedema is a high protein edema which forms when the lymphatic system is chronically
overwhelmed. Earlier fluid rich stages progress gradually toward enlargement and fibrosis of
the subcutaneous compartment and hyperkeratosis of the skin (elephantiasis) [1]. This can
occur as a result of congenital factors (primary lymphedema) but is more commonly caused by
an alteration in normal lymphatic function leading to secondary lymphedema. The majority of
secondary lymphedema occurs through infection with a vector-borne, parasitic disease known
as lymphatic filariasis (LF) which is endemic in 73 tropical countries where is it closely associ-
ated with poverty [2]. In developed countries lymphedema is more commonly a consequence
of some cancer treatments which involve lymph node removal or irradiation. Global estimates
of filariasis-related lymphedema (FR-LE) are 16.7 million cases [3] and cancer-related lymph-
edema (CR-LE) is estimated to affect between 15% and 80% of all cancer survivors [4]. Annual
mass drug administration (MDA) of anti-filarial chemotherapy can prevent future transmis-
sion of LF [5] and improvements in surgical management of cancer should reduce the inci-
dence of new CR-LE cases [6] but in both aetiologies onset of chronic symptoms may be
delayed for months, years or even decades after exposure to the risk [4, 7]. People with any
impairment to lymphatic function bear a lifelong risk of developing secondary lymphedema
[7].
Lymphatic vessels remove circulating fluid and large molecules from the extracellular spaces
of almost all body tissues and transport them to the lymph nodes. This is essential for
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continuous clearance of pathogenic elements crossing the skin barrier and entering the subcu-
taneous compartment and in other tissues it is vital in maintaining correct extracellular fluid
balance. Cleaned and filtered lymph is returned to systemic circulation via the vascular system.
In lymphedema, when normal lymph transport is impeded, protein rich fluid accumulates,
mostly in the subcutaneous compartment. Risk of infection is increased; namely acute der-
mato-lymphangio-adenitis (ADLA) in FR-LE, and cellulitis or erysipelas in CR-LE. Infection
then exacerbates disease progression and as lymphedema advances, symptoms become increas-
ingly disabling and disfiguring [8]. In areas endemic for LF, lymphedema causes social stigma,
superstition and loss of opportunity to marry [9]. People with CR-LE report depression, poor
quality of life and an inability to engage in paid employment [10].
Although essentially the same chronic disease, treatments for FR-LE and CR-LE follow dif-
ferent guidelines. The World Health Organization recommends community based home care
(CBHC)[5, 11–13] to improve hygiene and reduce ADLA episodes (the main cause of lost
working days) in FR-LE. The program promotes frequent washing and drying of affected areas
with particular attention to entry lesions (potential sites of fungal and bacterial infection), pas-
sive elevation and range of motion (ROM) exercises, and the use of oral antibiotic or anti-
inflammatory medications during acute events. Self-massage and compression bandaging are
recommended in advanced stages but usually not implemented in resource-poor settings [14].
In contrast the gold standard for CR-LE is a two phase program with an initial, intensive period
of therapist based treatment applying specialized lymphatic massage and multilayer compres-
sion bandaging to reduce limb size; followed by an ongoing maintenance phase of self (or part-
ner) lymphatic massage with regular use of compression garments [15]. Meticulous skin care
and remedial exercises are a component of both phases.
Established lymphedema is considered to be irreversible, necessitating lifelong care, and
family and psychosocial support [1]. Effective management of either FR-LE or CR-LE can
improve quality of life for the individual, reduce the burden on family resources and benefit
the local community. In developing countries there may be few or no health care services avail-
able for people with FR-LE and resources allocated to CR-LE treatment in many developed
countries are also insufficient [16, 17]. Poor access to lymphedema health services in both set-
tings and limited evidence of treatment efficacy has resulted in misinformation and unproven
management practices. Approaches to management will ultimately be shaped by access to
resources and cultural, financial and political influences [17], but effective core strategies that
can be applied across cultural and economic borders need to be identified. This review was
undertaken to evaluate the outcome of current self-care interventions for FR-LE and CR-LE.
Differences and similarities were assessed with respect to self-care components included in the
intervention, outcome measures used and the extent of any support services and monitoring.
The results have illuminated beneficial practices that may inform health systems in any setting
to increase the effectiveness of self-care strategies for people with secondary lymphedema.
Methods
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) state-
ment [18] guided the methodology of this review (protocol registration number
CRD42013004850). The research question and search terms were determined using the PICO
model (population, intervention, comparison, outcomes) [19]. Participants were defined as
people with established FR-LE or CR-LE. Interventions were any type of self-care procedure
that could be performed by an individual or within the family group and these included differ-
ent self-care protocols or specific components of self-care such as self-massage or resistance
exercise. Comparisons were either between groups in studies with more than one study group
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performing self-care, or before- and -after cohort studies (controlled or uncontrolled).Out-
comes were at least one of either a change in objective measure of lymphedema status (such as
lymphedema stage, limb volume or limb circumference) or change in frequency or duration of
acute episodes (ADLA or cellulitis). Additional optional outcomes were functional or perceived
disability, and self-reported symptoms.
Search strategy
Searches were conducted in Medline (OVID), CINAHL and Scopus databases in October 2013
and updated during March 2015. Medical Subject Headings (MeSH) were used in the Medline
search and keywords for the Scopus and CINAHL searches were derived from the Medline
MeSH terms to ensure consistency of search terms (Table 1). The search strategy was limited
to publications in English and grey literature was not searched. Reference lists of studies and
reviews, World Health Organization (WHO) summary reports and editorials were searched to
find other original peer reviewed studies. After removal of duplicates the title and abstract of
returned studies were screened by two authors (JD, SG). Full inclusion and exclusion criteria
used are detailed in S1 Tables.
Types of studies. The Australian National Health and Medical Research Council
(NHMRC) hierarchy of evidence [20] advocates randomised controlled trial (RCT) as the most
appropriate study design to answer clinical questions such as the effectiveness of self-care for
lymphedema. However, ethical issues may prevent comparison of basic self-care to no self-care
and no such trials were found. Therefore, this review included randomized or quasi-random-
ized comparisons of different types of self-care, as well as before and after cohort studies (con-
trolled or uncontrolled). Studies, including RCTs, where the primary outcome was assessment
of a drug or therapist based intervention were accepted if before and after measures for any
self-care group(s) was included. When such a study had only one group which met the inclu-
sion criteria for the review, the results of this group were considered during data extraction as
for an uncontrolled before and after cohort study.
Studies were excluded if they employed electrical devices, compression pumps or any equip-
ment such as swimming pools which would not be readily available in an average household.
Studies were also excluded if the intervention was not solely self-care i.e. required a surgical
procedure, was applied by a therapist, or if exercises were performed in instructor led classes.
Studies where the primary outcome was quality of life (QOL), socioeconomic factors or evalua-
tion of program implementation were included only if they also reported objective measures of
lymphedema status or frequency of infection.
Table 1. Keywords used to search databases.
Search Keywords
Search 1 ((lymphoedema or lymphedema or elephantiasis) and (filariasis))
Search 2 ((lymphoedema or lymphedema or elephantiasis) and (cancer or
oncology))
Search 3 1 OR 2
Search 4 (self-care or "self care" or basic-care or "basic care" or "community
based home care" or "community-based home-care" or "self
management" or self-management or self-treatment or "self
treatment" or self-massage or "self massage" or "partner massage"
or home-care or "home care" or limb-care or "limb care" or foot-care
or "foot care" or hygiene or breathing or exercise)
Search 5 3 AND 4
doi:10.1371/journal.pntd.0004740.t001
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Assessment of study quality
Two authors (JD, SG) independently appraised the included studies for methodological quality
using the Critical Appraisals Skill Program (CASP) RCT appraisal checklist or cohort appraisal
checklist appropriate to the study design [21]. A rating of strong, moderate or weak was
awarded to each study according to the number of ‘yes’, ‘can’t tell’ and ‘no’ responses. Studies
without ‘no’ or with two or less ‘can’t tell’ answers were considered methodologically strong.
Studies with one ‘no’ or three ‘can’t tell’ answers were rated moderate and studies with two or
more ‘no’ answers rated weak [22]. When the independent appraisal process was completed,
studies which did not achieve the same rating by both reviewers were discussed until agreement
was reached. A third reviewer (PG) was available where discrepancies could not be resolved
but was not required.
Data extraction and synthesis
One author (JD) independently extracted study data including number of participants, inter-
vention, outcomes, outcome measures, and results. Special characteristics of gender, age, coun-
try/setting, lymphedema cause, affected site and stage (or grade) of lymphedema were noted.
Data were extracted for change in lymphedema status and effect on acute episodes. Where
results were reported consistently with appropriate estimate of precision, a meta-analysis was
performed using Review Manager version 5.3 (The Nordic Cochrane Centre, 2014). Data on
effect size and outcomes of clinical importance were extracted for narrative synthesis and to
highlight differences between the FR-LE and CR-LE studies.
Results
Combined searches including reference lists, hand searches and expert referrals yielded 1008
unique articles of which 940 were excluded by title or abstract. Sixty-eight full text articles were
screened with 28 meeting the criteria for inclusion. Fig 1 shows the PRISMA flow diagram of
study selection and details exclusions by criteria.
Study design
Ten RCT’s including one quasi RCT and one randomized cross over trial were included. Of
these, three FR-LE trials [23–26] and two CR-LE trials [27, 28] compared two or more groups
performing different self-care protocols. The remaining five RCTs included only one group
using self-care alone and these results were considered as uncontrolled, prospective cohorts
[29–33]. Most cohort studies were prospective: ten on FR-LE, including two reports on the
same cohort [34, 35], and four on CR-LE. There was one retrospective follow up on a previous
FR-LE RCT and two retrospective reports on CR-LE.
Quality rating and risk of bias. Two RCT’s were rated as strong but only one of these
compared two groups that could be included for review [24]. Of the five RCTs rated as moder-
ate one had two groups performing self-care [27] and four included only one group which met
the inclusion criteria. The main risks of bias among the RCTs were inadequate blinding, dispar-
ity of participants at baseline and unequal treatment of groups. No cohort studies were rated as
methodologically strong and five were rated as moderate quality [35–39]. Risks of bias
included: recruitment by convenience sampling, insufficient consideration of confounding fac-
tors, low measurement sensitivity and large loss to follow up. Overall 16 studies (57%) were
rated as weak methodological quality. The methodological quality rating of each study is pro-
vided in S1 Tables.
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Population
There were eighteen reports on seventeen studies about FR-LE and all were conducted in tropi-
cal countries endemic for Brugia malayi orWuchereria bancrofti. All participants had leg
lymphedema, three included people with arm lymphedema [14, 25, 40] and two did not specify
Fig 1. PRISMA flow chart of search results.
doi:10.1371/journal.pntd.0004740.g001
Self-Care for Management of Secondary Lymphedema: A Systematic Review
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004740 June 8, 2016 6 / 20
the affected limb [33, 41]. Both genders were represented with a greater proportion of females
(42.5% - 87%) and although children were admitted in 14 studies most participants were adults
with a mean or median age between 35 and 57 years (range 10 to 98 years). Sample sizes ranged
between 14 and 1578 with 14 studies of more than 90 participants.
In contrast to FR-LE, most participants in the ten CR-LE studies were women with arm
lymphedema after breast cancer and only one RCT included males and participants with leg
lymphedema [27]. Other than one Indian cohort [42] all were conducted in developed coun-
tries; sample sizes were smaller and four studies had less than 30 participants (range 18–138).
Compared to FR-LE studies, the mean or median age of participants in CR-LE studies was
higher, between 47 and 66 years (range 25–87 years) and none included adolescents. Popula-
tion characteristics for all studies are provided in S2 Tables.
Assessment of limb status
Staging (or grade) of lymphedema was based on clinical assessment of limb size and skin
changes. FR-LE studies used either the WHO criteria of Grades 1–3 [43], WHO criteria of
Grades I–IV [44] or a seven stage criteria developed by Dreyer, Addiss [11]. CR-LE studies did
not state the staging criteria used. Two CR-LE [29, 42] and three FR-LE studies [32, 36, 39]
excluded participants with later stages of disease and participants with lymphedema stage 0
were included in two FR-LE studies [30, 36]. The water displacement method [45], which is
considered the international gold standard [1], was used to calculate limb volume in both
CR-LE and FR-LE studies. Only studies on CR-LE used electronic measuring devices, specifi-
cally; multi-frequency bio-impedance spectroscopy which measures extracellular fluid loads
[46] and perometry which calculates limb volume using a truncated cone formula from cir-
cumferences at 3 millimetre intervals [47]. Limb circumference by tape measure was included
in most studies and reported as limb volume, calculated using a truncated cone formula at four
or five centimetre intervals, as raw circumference values at fixed points or as a combined aver-
age of all points. Studies on unilateral lymphedemas frequently reported on relative limb vol-
ume (difference between the affected and unaffected limbs) and percentage change in relative
limb volume (RLV) over time. Methods used to assess limb status in each study are provided in
S2 Tables.
Interventions
Basic self-care. Basic self-care in FR-LE studies centred on meticulous skin care including
frequent washing and drying of the affected limb with soap and water, limb elevation while
sleeping and during the day when possible, range of motion (ROM) exercises and application
of topical creams to entry lesions. Hygiene equipment such as bowls, soap and towels were pro-
vided in nine studies [23, 32, 35, 36, 39, 40, 48–50]. Medicated topical creams and oral antibiot-
ics or anti-inflammatories were recommended or supplied for treatment of ADLA in all
prospective studies. In CR-LE studies meticulous attention to skin integrity took the form of
regular use of emollients and attention to nail care rather than instruction in washing and dry-
ing. Remedial exercises and compression garments were also universally recommended.
Additional components of self-care. After basic self-care, the most studied intervention
was a home based exercise program on women with CR-LE after breast cancer which included
resistance exercise (using gravity or light weights to provide resistance against muscular con-
traction) [28, 31, 42, 51], pole walking [52], yoga [38] or deep breathing with gentle arm exer-
cise [53]. Self-lymphatic drainage (SLD) is a form of gentle self -massage used to promote the
flow of lymph and was taught or recommended in several studies [27, 29, 37, 38], one RCT
compared selected essential oils blended into the massage medium to plain cream [27]. Three
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RCTs on FR-LE compared medicated soap [23] or medicated cream [24, 25] to plain soap or
cream in the daily self-care routine and two included one group who used antiseptic ointment
daily [30, 33]. Compression therapies were recommended in all CR-LE studies, either as con-
tinued use of a previously prescribed garment [27, 31, 38, 42, 53] or a new compression sleeve
supplied at study commencement [28, 29, 51, 52, 54]. One FR-LE study trained participants in
self-bandaging and provided custom made garments [37] while another recommended the use
of compression but reported infrequent or no use among participants [14]. No CR-LE studies
utilized self-bandaging.
Instruction in self-care. Most self-care protocols were delivered to individuals and their
families or carers in outpatient clinics or in-home settings and ranged from a single hour of
education and demonstration [29, 32, 38] to daily training over 4 days [37]. Those studies
which stipulated a published protocol for morbidity management of FR-LE followed the WHO
Community Based Home Care guidelines [14, 34, 35] or the ‘New Hope for People with Lym-
phoedema’ booklet by Dreyer, Addiss [11] [32]. Six FR-LE and three CR-LE studies received
printed instructions [14, 36, 37, 40, 41, 49] [28, 38, 42] and two CR-LE studies delivered home
support through digital media [31, 38].
Monitoring and follow-up. Participants in most FR-LE studies attended fortnightly or
monthly home or clinic visits with extra, surprise field checks in five studies [24, 25, 30, 36, 48].
Some participants were able to access a clinic or health care worker as needed [41, 50] while oth-
ers recorded ADLA events in a log book [32, 49]. Participants in all prospective CR-LE studies
attended measurement clinics at intervals of between two and twelve weeks. Overall FR-LE inter-
ventions were of longer duration, typically 12 months (range 4.5–36 months), five followed par-
ticipants for 12 months after the intervention ceased [24, 25, 32–35] and one was a retrospective
follow up on participants in a previous trial by Shenoy, Kumaraswami [25] after 12 months of
unsupervised self-care [55]. Compared to FR-LE studies CR-LE studies were generally shorter
(range 1–6 months) and only two studies followed subjects for 12 months [29, 54].
Effects of interventions
Basic self-care for FR-LE. Effect of basic self-care on ADLA in FR-LE. Eleven studies
reported on this outcome (n = 2954). Episodes of ADLA were assessed in a clinic, recorded in a
log book or by participant report. Before and after periods were unequal in some studies which
reported baseline ADLA using patient recall of the previous 12 months and then collected data
as frequently as every two weeks during the intervention.
Proportion of persons experiencing ADLA episodes. Results of eight studies were com-
bined to estimate the effect of basic self-care on ADLA episodes (Fig 2). A random effects
model was used due to a high level of heterogeneity between results (I2 = 96). Overall, the pro-
portion of participants reporting any ADLA attacks was reduced by 54% (RR = 0.46; 95% CI
0.26 to 0.82). Five studies reported significant reduction in the proportion of participants who
experienced any ADLA [14, 36, 39, 40, 50] and two found non-significant reductions [41, 55].
Only the placebo drug group in an RCT reported an increase in persons experiencing any
ADLA over 24 months (RR = 1.09, 95% CI 0.74, 1.63) [32]. In the pseudo-RCT which com-
pared three service delivery methods the proportion of participants who reported no episodes
in the preceding 6 months increased from 6% at baseline to 93.5% after 12 months [50].
Frequency and duration of ADLA. Seven studies reported on this outcome. Six prospective
cohorts (n = 1471) found that ADLA frequency or duration reduced between 26% and 100%
after 6 to 24 months of self-care [35, 39, 48, 50] and this was significant in two cohorts [14, 36].
Where ADLA incidence was reported by lymphedema stage the best improvements were among
participants with stages III and IV (81.3%, p = 0.022) and stage II (80.8%, p<0.001) [14] and
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more than 60% reduction was achieved in all stages after 6 months [35] and 12 months [48].
Four studies found either; a decrease in the mean duration of ADLA episodes (range 24% -
37.5%) [14, 48] or in the number of working days lost (mean 39%, range 28% - 44%) [34]. In the
pseudo RCT the proportion of participants who had experienced ADLA that lasted more than 4
days in the previous year dropped by 78.6% and although 23.4% had reported ADLA that lasted
seven days or more at baseline, by the end of the study this had reduced to none [50]. The retro-
spective follow up of participants in a previous trial by Shenoy, Kumaraswami [25] showed that
some benefits were lost 12 months after monitoring ceased and mean ADLA incidence had
increased by 65% [55], however this was still 40% lower than before commencement of self-care
in the original RCT. The study by Mues, Deming [35] also found that although the significant
reductions in ADLA achieved at 6 months (60%) were partially lost after 12 months, the rate
remained lower than at baseline (35%) and this was maintained at 24 months. Results of basic
self-care on frequency and duration of ADLA episodes are provided in S3 Tables.
Effect of basic self-care on FR-LE status
Seven studies (n = 1073) reported on change in either objective assessment of lymphedema
stage or limb volume, or participant perception of limb status. WHO staging criteria was used
Fig 2. Forest plot of the proportion of FR-LE participants experiencing any ADLA episodes.
doi:10.1371/journal.pntd.0004740.g002
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more frequently (four studies) than the seven stage Dreyer system (two studies). Limb volume
was quantified by water displacement (three studies) or limb circumference (three studies).
Changes in limb volume. In a study which excluded participants with stages 5–7 using
the Dreyer, Addiss [11] criteria, limb volume reduced in stages 0–4 after 12 months and this
was significant in stages two and three which reduced by 4% and 17.1% respectively [36]
(Table 2). In a cohort with unilateral leg lymphedema participants who reported a perceived
reduction or no change in limb volume (54%) were more likely to have earlier stage FR-LE
whereas participants who reported a perceived increase (46%) were more likely to have later
stages of disease [48].
Change in lymphedema stage. Three reports on two studies (n = 533) found a significant
proportion of participants had reverted to a lower stage after 12 [14] and 24 months [34, 35] of
basic self-care. This effect was greater in participants with early or moderate stage FR-LE,
whereas the proportion of people with more advanced disease either stayed the same [35] or
increased slightly (not significant) (Table 3). Other studies reported no change in lymphedema
stage [32, 39].
Effect of basic self-care on perceived disability and QOL in FR-LE
Two studies reported on this outcome using either the Dermatology Quality of Life Index
(DQLI) [56] or the WHO Disability Assessment Schedule II (WHO DAS II) [57]. Both studies
used the seven stage criteria for FR-LE and reported significant improvement in either; all
stages after 12 months (n = 14) [41] or in stages 3–7 after 24 months (n = 370) [34]. Results for
changes in perceived disability and quality of life are provided in S3 Tables.
Table 2. Change in FR-LE limb volume after 12 months of self-care in Addiss et al 2010 [36].
Stage # Baseline Mean ml (range) * After 12 months Mean ml (range) * N (legs) % reduction P
0 1610 (1080–2160) 1604 (1310–2130) 26 0.3%
1 1937 (1515–2760) 1786 (1470–2030) 9 7.8%
2 1986 (1450–2835) 1909 (1230–2970) 41 4.0% p<0.05
3 2839 (1920–3700) 2354 (1580–3260) 15 17.1% p<0.05
4 3644 (2390–4760) 3082 (1510–4010) 5 15.4%
# Dreyer et al 2002 [11]
ml = millilitres
* Water displacement method
doi:10.1371/journal.pntd.0004740.t002
Table 3. Proportion of Participants by FR-LE stage after 6–24 months of self-care.
Study ID Stage Baseline 6 months 12 months 24 months
Mues et al 2014[35] and Budge et al 2013[34]1 1–2 48.73% 54.01% 55.76% 60.13% p = 0.0064
3–4 37.57% 32.41% 30.22% 25.32% p = 0.0006
5–6 12.70% 13.58% 14.02% 14.56%
Wijesinghe et al 2007[14]2 I 8.6% n/a 16%* n/a
II 52.7% n/a 46% n/a
III 31.3% n/a 31% n/a
IV 7.4% n/a 8% n/a
*Eleven people reverted from Stage II to Stage I (p = 0.012)
1 = Stages per Dreyer et al 2002 [11]
2 = Stages per WHO 2003 [13]
doi:10.1371/journal.pntd.0004740.t003
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Basic self-care for CR-LE
No study assessed the effect of self-care alone on CR-LE.
Self-care using topical medication for FR-LE
Five studies (n = 460) used medicated creams or soap in the daily self-care protocol. Three
RCTs were used to compare either medicated soap [23] or medicated cream [24, 25] to plain
soap or plain cream and medicated ointment was used daily by one self-care group in two
other trials [30] [33]. All interventions were of 12 months duration and three studies followed
participants for a further year after the intervention ceased [24, 25, 33].
Effect of self-care with topical medication on frequency and duration of
ADLA
Neither of the RCTs which compared medicated cream to plain cream found any between
group differences. After the 12-month intervention a significant reduction in annual ADLA
episodes of between 63.83% [25] and 77.57% [24] was recorded by all groups and at 24 months
the mean annual incidence was still significantly lower than at baseline by 59.52% and 65.02%
respectively. During the follow up year, annual incidence in the groups who had used plain
cream during the intervention continued to reduce, whereas both groups who had used antibi-
otic cream experienced an increase (not significant). The trial which compared antibiotic soap
to plain soap also found no difference between groups and reported results as for a single
cohort [23]. This cohort and the medicated cream groups in two trials (n = 340) all reported
significant reductions in mean ADLA episodes of between 62.5% and 65.6% after 12 months
[23, 30, 33]. One group was followed for 12 months after the intervention and an overall reduc-
tion of 73% from baseline was recorded [33]. Results of the effect of medicated cream or soap
on ADLA are shown in S3 Tables.
Effect of self-care with topical medication on FR-LE status
Two trials reported on this outcome (n = 120). In a 12-month intervention on unilateral leg
lymphedema [30], raw circumference values for the affected limb reduced between 27.6% -
92% with the greatest reduction at the calf of participants with Grade 2 FR-LE (WHO grades
1–3 [43]) and the least reduction at the ankle in participants with Grade 3 (Fig 3). In this trial
the difference in circumference between affected and unaffected limbs also reduced signifi-
cantly at all time points. In the trial which used water displacement to measure limb volume at
baseline and then again during ADLA [24], limb volume increased during 80% of episodes and
remained elevated in 73% of cases after two weeks.
Self-care using topical medication for CR-LE
No CR-LE studies investigated the addition of medicated creams or soaps.
Home based exercise for FR-LE
No studies assessed the effect of prescribed exercises on FR-LE.
Home based exercise for CR-LE
Seven studies assessed exercise interventions of between eight weeks and six months duration.
All participants were women with unilateral arm lymphedema after breast cancer (n = 197)
and six studies reported significant benefits in at least one outcome.
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Effect of home based exercise on CR-LE status
Change in limb volume. Results of three studies that reported on change in relative limb
volume (RLV) (difference between the affected and unaffected limbs) were combined to estimate
the effect of home exercise (Fig 4, n = 54). A random effects model was used due to a high level of
heterogeneity between results (I2 = 0). Overall, RLV reduced by 1.31% (95% CI -4.73, 2.11).
Statistically significant reduction in limb volume was recorded 10 minutes after commenc-
ing a deep breathing exercise with gentle arm movements [53], after eight weeks of pole walk-
ing [52] or isotonic arm exercises with deep breathing [42], after ten weeks of weight lifting
[51] and in both groups after 12 weeks of either gravity resisted exercise or self-care with hand
pumping [28]. In the latter trial both groups had reduced further after six months but this was
significant only in the gravity resisted exercise group. This trend was supported by a reduction
in arm volume in the home based exercise group in an eight week trial [31] and in a group of
women who practiced yoga at home for six months after an initial four week intervention [38]
Fig 3. Change in FR-LE limb circumference after 12 months of medicated cream use.
doi:10.1371/journal.pntd.0004740.g003
Fig 4. Forest plot of percentage change in relative CR-LE limb volume after exercise.
doi:10.1371/journal.pntd.0004740.g004
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whereas the participants who discontinued yoga practice had experienced an increase (not sig-
nificant). Results of the effect of home based exercise on limb volume are given in S4 Tables.
Effect of home based exercise on limb function, self-reported symptoms
and QoL
Seven studies (n = 295) reported improvement in one or more of these outcomes.
Change in limb function. Significant improvements were found in grip strength [31],
muscle strength [51] and cardiovascular fitness [52] but not in ROM [28]. Three studies
reported an improvement in participant perception of limb function using various versions of
the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire [58] and this was signif-
icant in the home exercise group in one RCT [31].
Change in self-reported symptoms. Likert scales and visual analogue scales were used to
assess participant perception of symptoms in the affected limb in four studies (n = 143). Signif-
icant improvement was found in; pain, heaviness, tightness, pins and needles, and perception
of limb size after one month of deep breathing with gentle arm exercise arm [53] and in arm
tightness after eight weeks of pole walking [52].
Change in quality of life. Two studies on home based exercise reported significant
improvement in all domains of the Short Form 36 Health questionnaire after eight weeks [42]
and in the Functional Assessment of Cancer Therapy–Breast (FACT-B) after 12 weeks [31].
Self-lymphatic drainage (SLD) and compression therapies for FR-LE
Only one FR-LE study emphasized the use of SLD and instructed participants in daily self-ban-
daging. After three weeks of self-bandaging they were fitted with compression garments which
were then worn daily for the remainder of the study [37]. Although the self-care protocol in the
study by Wijesinghe, Wickremasinghe [14] recommended compression it was not routinely
used and results of that study were reported in the basic self-care section.
Effect of SLD and compression on FR-LE status
Change in limb volume. Significant reductions were recorded after three, six and nine
months of performing comprehensive self-treatment including compression therapy (n = 33
legs) [37]. Results for this study are provided in S3 Tables.
Self-lymphatic drainage (SLD) and compression therapies for CR-LE
One study on both arm and leg lymphedema [27] and two studies on arm lymphedema [29,
54] included SLD in the self-care program (n = 121). The RCT with the mixed arm and leg
population investigated the benefits of using Aromatherapy (essential oils) in the massage
medium compared to plain cream but found no significant difference between groups and
reported most results as a single cohort using SLD [27]. No CR-LE studies included self-ban-
daging but regular use of a compression garment was recommended in all studies. New gar-
ments were supplied at commencement in four studies [28, 29] of which two [51, 52] allowed a
control period before the intervention to adjust for the effect of the garment.
Effect of SLD and compression on CR-LE status
Change in limb volume. Two studies that used SLD with compression garments [27, 54]
and one group of women that had mild arm lymphedema and used SLD without compression
[29] reported significant reduction over three and six months of between 2.59 and 60%
(Table 4, n = 121). In the six-month trial of SLD on people with both arm and leg lymphedema,
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significantly more participants experienced an improvement in limb volume than got worse
[27].
Effect of SLD and compression on self-reported symptoms and wellness
in CR-LE
The Measure Yourself Outcome Profile 2 [59] was used to assess quality of life in participants
performing SLD with or without Aromatherapy and both groups reported significant improve-
ments at all time points up to 6 months [27].
Discussion
In reviewing the evidence for self-care in FR-LE and CR-LE, marked differences were apparent
both between and within settings and some key opportunities for improvements were identi-
fied. Evidence from the FR-LE population showed that basic self-care alone is effective in pre-
venting ADLA which is consistent with results of a recent review of the effect of hygiene based
interventions on FR-LE [60]. Hygiene alone may halt disease progression but is less likely to
reduce limb volume and evidence from the CR-LE population indicated that greater volume
reductions are achieved when activities such as progressive resistance exercise are included in
the self-care routine. Whilst basic self-care was the primary intervention in almost 60% of stud-
ies on FR-LE, no CR-LE studies assessed basic self-care alone; rather the self-care group when
included were always as controls. Best practice guidelines in CR-LE management are still
dependent on therapist performed interventions; however evidence from the FR-LE population
suggests that more effort to involve CR-LE patients in their own self-treatment may relieve the
financial burden of therapist based care in this population.
The exclusion of any group in comparative studies that received drug or therapist based
interventions meant that although ten RCTs were reviewed the bulk of evidence came from
observations of a single cohort in studies rated of moderate or weak methodological quality
where only one or two groups were performing self-care. There was also inconsistency between
assessment techniques and reporting methods. Therefore a review which includes all interven-
tions for FR-LE and CR-LE may provide data for more rigorous meta-analysis. None the less,
this first review to systematically examine the similarities and differences in self-care for
Table 4. Change in CR-LE limb volume (ml) after 3–6 months of SLD.
Study ID Limb |Duration (months)| Before Intervention After Intervention % Reduction (95% CI)
Limb Volume ml N Volume ml N
Anderson et al 2000[29] Upper limb (RLV)2 Median (range) 3 361 (78–1184) 22 n/a 22 60% (43% - 78%)
Barclay et al 2006[27] Upper limb (RLV)1 Median (range) 6 107.0 (-372.0–2421.0) 81 60.0 (-334–2344) 71 43.92%
Barclay et al 2006[27] Right lower limb (WLV)1 Mean (SD) 6 6218.3 (1772.5) 81 6057.1 (2093.0) 71 2.59%
Barclay et al 2006[27] Left lower limb (WLV)1 Mean (SD) 6 6177.9 (1857.9) 81 5797.9(2014.9) 71 3.20%
Koul et al 2007[54] Upper limb (WLV)1 Mean 3 2685 18 2587 18 24% p<0.0001
WLV = Whole limb volume
RLV = Relative limb volume, difference between affected and unaffected limbs
1 = Volume calculated from limb circumference at 4cm intervals
2 = Volume calculated from limb circumference at 5cm intervals
SD = standard deviation
n/a = data not provided
doi:10.1371/journal.pntd.0004740.t004
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CR-LE and FR-LE has opened a pathway for further investigation of transferrable strategies for
lymphedema management in disparate settings.
The available resources in each study setting were reflected in the simplicity or complexity
of devices used to measure change in limb status. All CR-LE studies used water displacement,
bio impedance spectroscopy, perometry or a truncated cone formula at small intervals to quan-
tify limb volumes. These methods can detect very small changes which, although statistically
significant, might be of minimal clinical significance. In contrast most FR-LE studies relied on
less precise measures and less than one quarter used either water displacement or a truncated
cone formula. A further 18% of studies used three or four fixed circumference points to com-
pare affected and unaffected limbs or summed or averaged these measures. These methods,
especially summed or averaged circumferences lack the precision to detect small changes in
limb volume and this could account for variations in reported outcomes between the CR-LE
and FR-LE groups. More frequently, FR-LE studies relied on assessment of lymphedema by
stage and the use of criteria with only three or four groups was common, since even studies
which used the seven stage criteria often grouped them into early, moderate or late stage dis-
ease. These graduations may lack the precision to detect small changes and participants who
changed from a higher to a lower stage or vice versa may not have always been detected,
thereby under or over estimating the effectiveness of the intervention. Most studies tried to
minimise inter- or intra-observer variation in staging but the subjective nature of these assess-
ments may also have contributed to the disparate results. These limitations may explain why
some studies reported reduction in limb volume without a corresponding change in lymph-
edema grade. Overall studies which used more precise measuring protocols more often
reported significant evidence for volume reduction in both settings.
Less than 12% of FR-LE studies investigated the effect of self-care on subjective symptoms
or functional deficits whereas this was reported in 70% of CR-LE studies. The evidence for
improvement was weak, mainly due to the disparate range of measuring tools employed, but
the overall trend was that a reduction in limb volume was accompanied by improvements in
symptoms, perceived disability, overall wellbeing and quality of life. This suggests that self-
reported parameters could be used as a proxy for objective measures when these are not avail-
able and provide valuable information about the lived experience of FR-LE.
Oral or topical medications for ADLA were used in almost all FR-LE studies but the influ-
ence of these could not be adequately separated from the effect of other components of self-
care and it is unclear what bearing this had on the results. Although groups treated specifically
with oral antibiotic or deworming medications were excluded from the data synthesis some
reports showed that the placebo drug groups performing basic self-care had better long term
results than groups that had initially received oral medications [24, 25, 33]. Studies on topical
medications for ADLA showed no additional benefit over self-care using placebo creams or
soaps and the necessity of prophylactic oral medication for ADLA remains controversial. Simi-
larly, in CR-LE studies the use of a compression sleeve was considered an integral aspect of
self-care but few studies controlled for the effect of a new garment or included frequency of
garment use in the statistical analysis. Where this was done the effect of the compression sleeve
was shown to be significantly correlated with improvement in all groups. Whilst these treat-
ments might be considered to be core elements of self-care, access to medication in poorly
resourced settings and non-adherence to compression therapies in CR-LE warrant the investi-
gation of self-care protocols that do not rely on these components.
Effective self-care implementation requires some degree of education, instruction or dem-
onstration and the role of the educated health worker or trained volunteer cannot be ignored.
FR-LE studies which provided frequent monitoring and support were associated with greater
improvements than studies which offered minimal or no support services. The study by Suma,
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Shenoy [55] which retrospectively reviewed participants in a previous drug based RCT indi-
cated that without monitoring, program effectiveness is lost over time, an effect also found in a
later follow up of the study by Addiss, Louis-Charles [36] which could not be included in this
review [61]. Ultimately, the long term success of any self-care intervention will depend on indi-
vidual ownership of and adherence to the daily self-care practices and the level of family or
local support available. This was demonstrated clearly in the study by Akogun and Badaki [50]
where one group was able to alter the program design to suit their immediate cultural and
social constraints and reported good outcomes, whereas the two groups who could not alter
the program design to suit their personal circumstances experienced a large loss to follow up.
Despite the wide variation in measurement techniques and support services, it was apparent
that hygiene-centred, basic self-care can reduce the frequency and duration of ADLA episodes
by approximately 50%, and this was particularly beneficial for people with later stages of dis-
ease. There was less evidence for a reduction in limb volume but the study by Joseph, Mony
[24] showed that ADLA led to an increased limb volume which persisted after the infection
had been treated and Mues, Deming [35] demonstrated that ADLA is related to days of work
lost. Thus a reduction in ADLA episodes without change in limb size may still improve out-
comes for many individuals. This was illustrated histologically in the study by Wilson, Guarner
[39] which showed that basic self-care improved skin integrity and prevented new infections
while limb stage remained the same. Where a reduction in limb volume was reported in FR-LE,
greater benefits were experienced among participants with early stages, suggesting that imple-
mentation of a self-care routine as soon as lymphedema is detected has the potential to curtail
the number of cases that progress to advanced stages. Current guidelines for FR-LE will not
assist program managers to find and address these earliest stages of lymphedema yet this may
be the optimal time to intervene in terms of volume reduction and long term prevention of
ADLA. Basic hygiene is enough to control ADLA but this review has shown that limb volume
is more difficult to reduce in later stages regardless of the setting [27, 48]. Advanced lymph-
edema is characterised by fibrosis and fatty induration of the tissues which become much more
difficult to reduce than in early stages where the swelling is more characteristically due to pro-
tein rich fluid. So to reduce limb volume more intervention is required at an earlier stage than
is currently indicated in the WHO guidelines.
Reduction in limb volume was reported in all CR-LE studies, all of which included at least
one additional component of self-care. Since publication of the 2005 study by Moseley, Piller
[53], specific deep breathing exercises appear frequently in interventions for CR-LE as was evi-
denced by their inclusion in six studies in this review. Home based exercise, including deep
breathing, is easy to perform, require no financial resources, can be continued alone after mini-
mal initial instruction and may contribute to overall improvement in health and wellbeing, but
exercise advice included in the current protocols for FR-LE is very limited. Simple resistance
exercise and deep breathing could be easily incorporated into CBHC particularly in cultures
where activities such as Yoga or Tai Chi may be readily available and acceptable and the addi-
tion of such components to current WHO recommendations warrants investigation.
In FR-LE, issues pertaining to infection, wet environments and lack of foot wear make com-
pression therapies problematic. However, Bernhard, Bernhard [37] and other studies that
could not be included in this review [62] have showed that people with FR-LE are capable of
performing complex compression bandaging and daily use of compression garments. This
requires a greater initial investment in the training and education of people with FR-LE so that
they have a better understanding of the purpose and effect of each treatment component. The
long term benefit of this increased investment was demonstrated in the study by Bernhard,
Bernhard [37] where limb volume reduction was significantly greater in the self-treating group
compared to the therapist treated group (results for the therapist treated group were not
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included in this review). This supports consideration of compression therapies in FR-LE when
possible and although the evidence is limited, also suggests that self-bandaging could be further
explored for people with CR-LE.
Although people with arm lymphedema were included in several FR-LE studies, results
were not reported by limb. Only the CR-LE study by Barclay, Vestey [27] reported results by
affected limb and in this study the impact of SLD on volume reduction was much greater for
arms than legs. This limited comparison of results by limb implies that interventions may
deliver different results depending on the location of the lymphedema. Similarly, some studies
allowed participation of children as young as five years old but no study gave an analysis by age
to determine if children had better or worse outcomes than the adult subjects, nor was the
effect of gender explored. It is possible that age and gender influence self-treatment outcomes
and investigation of different components of self-care by limb, age and gender should be
considered.
Since disability from existing LF will continue to increase for several decades even after
transmission has been successfully interrupted, and increasing cancer survivorship is a primary
focus of cancer research, it is probable that the incidence of new lymphedema cases from both
causes will continue to increase for the foreseeable future. Focussing efforts toward greater
emphasis on early intervention and prevention has the potential to alleviate this future burden.
Implementation of morbidity management in the global effort to eliminate LF requires evi-
dence based strategies to attract and maintain funding, and reducing the burden of CR-LE for
all cancer survivors requires more research about lymphedema of the leg. In both cases high
quality studies that investigate reversal of early stage disease and analysis of individual compo-
nents of self-care by age, gender, stage and location of lymphedema are essential to determining
optimal, financially sustainable, management.
Supporting Information
S1 Tables. Inclusion criteria and methodological quality of assessed papers.
(DOCX)
S2 Tables. Population characteristics of all studies.
(DOCX)
S3 Tables. Effect of interventions on Filariasis Related Lymphedema (FR-LE).
(DOCX)
S4 Tables. Effect of interventions on Cancer Related Lymphedema (CR-LE).
(DOCX)
Author Contributions
Conceived and designed the experiments: JD SG. Performed the experiments: JD SG. Analyzed
the data: JD. Contributed reagents/materials/analysis tools: JD PG. Wrote the paper: JD SG
PG.
References
1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2009
Consensus Document of the International Society of Lymphology. Lymphology. 2009; 42(2):51–60.
PMID: 19725269
2. World Health Organization. Progress report 2000–2009 and strategic plan 2010–2020 of the global pro-
gramme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. WHO Library
Catalogue. 2010.
Self-Care for Management of Secondary Lymphedema: A Systematic Review
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004740 June 8, 2016 17 / 20
3. Ramaiah KD, Ottesen EA. Progress and impact of 13 years of the global programme to eliminate lym-
phatic filariasis on reducing the burden of filarial disease. PLoS Negl Trop Dis. 2014; 8(11):e3319. doi:
10.1371/journal.pntd.0003319 PMID: 25412180
4. Williams AF, Franks PJ, Moffatt CJ. Lymphoedema: estimating the size of the problem. Palliative Medi-
cine. 2005; 19(4):300–13. PMID: 15984502
5. World Health Organization. Lymphatic filariasis: managing morbidity and preventing disability: an aide-
mémoire for national programmemanagers. WHO Library Catalogue. 2013.
6. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment,
including sentinel lymph node biopsy. Lymphology. 2004; 37(2):73–91. PMID: 15328760
7. Armer J, Stewart B. Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months.
Lymphology. 2010; 43(3):118. PMID: 21226414
8. Ramaiah KD, Das PK, Michael E, Guyatt HL. The economic burden of lymphatic filariasis in India. Para-
sitology Today. 2000; 16(6):251–3. doi: 10.1016/S0169-4758(00)01643-4 PMID: 10827432
9. Zeldenryk LM, Gray M, Speare R, Gordon S, MelroseW. The Emerging Story of Disability Associated
with Lymphatic Filariasis: A Critical Review. PLoS Negl Trop Dis. 2011; 5(12). doi: 10.1371/journal.
pntd.0001366
10. Ridner SH. The psycho-social impact of lymphedema. Lymphatic Research and Biology. 2009; 7
(2):109–12. doi: 10.1089/lrb.2009.0004 PMID: 19534633
11. Dreyer G, Addiss D, Dreyer P, Noroes J. Basic LymphoedemaManagement, Treatment and Preven-
tion Problems Associated with Lymphatic Filariasis. USA: Hollis Publishing Company; 2002.
12. World Health Organization. Learners Guide: Training module on community home-based prevention of
disability due to lymphatic filariasis. Geneva: World Health Organization; 2003.
13. World Health Organization. Tutors guide: Training module on community home-based prevention of
disability due to lymphatic filariasis. Geneva: World Health Organization; 2003.
14. Wijesinghe RS, Wickremasinghe AR, Ekanayake S, Perera MSA. Efficacy of a limb-care regime in pre-
venting acute adenolymphangitis in patients with lymphoedema caused by bancroftian filariasis, in
Colombo, Sri Lanka. Ann Trop Med Parasitol. 2007; 101(6):487–97. PMID: 17716431
15. Lawenda BD, Mondry TE, Johnstone PAS. Lymphedema: A primer on the identification and manage-
ment of a chronic condition in oncologic treatment. CA Cancer Journal for Clinicians. 2009; 59(1):8–24.
doi: 10.3322/caac.20001
16. International Society of L. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus
Document of the International Society of Lymphology. Lymphology. 2013; 46(1):1–11. PMID:
23930436.
17. Stout NL, Brantus P, Moffatt C. Lymphoedemamanagement: An international intersect between devel-
oped and developing countries. Similarities, differences and challenges. Global Public Health. 2012; 7
(2):107–23. doi: 10.1080/17441692.2010.549140 PMID: 21360379
18. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA Statement
for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interven-
tions: Explanation and Elaboration. Plos Medicine. 2009; 6(7). doi: 10.1371/journal.pmed.1000100
19. Santos CMC, Pimenta CAM, Nobre MRC. The PICO strategy for the research question construction
and evidence search. Revista Latino-Americana de Enfermagem (RLAE). 2007; 15(3):508–11.
20. National Health and Medical Research Council. NHMRC additional levels of evidence and grades for
recommendations for developers of guidelines. Available: https://www.nhmrc.gov.au/_files_nhmrc/file/
guidelines/developers/nhmrc_levels_grades_evidence_120423.pdf; 2009.
21. Critical Appraisal Skills Program (CASP). CASP Checklists. Available: http://wwwcasp-uknet/. Oxford
2013.
22. Thomas B, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: pro-
viding the research evidence for public health nursing interventions. Worldviews on Evidence‐Based
Nursing. 2004; 1(3):176–84. PMID: 17163895
23. Addiss DG, Michel MC, Michelus A, Radday J, Billhimer W, Louis-Charles J, et al. Evaluation of anti-
bacterial soap in the management of lymphoedema in Leogane, Haiti. Trans R Soc Trop Med Hyg.
2011; 105(1):58–60. doi: 10.1016/j.trstmh.2010.08.011 PMID: 20850849
24. Joseph A, Mony P, Prasad M, John S, Srikanth, Mathai D. The efficacies of affected-limb care with pen-
icillin diethylcarbamazine, the combination of both drugs or antibiotic ointment, in the prevention of
acute adenolymphangitis during bancroftian filariasis. Ann Trop Med Parasitol. 2004; 98(7):685–96.
PMID: 15521106
25. Shenoy RK, Kumaraswami V, Suma TK, Rajan K, Radhakuttyamma G. A double-blind, placebo-con-
trolled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb
Self-Care for Management of Secondary Lymphedema: A Systematic Review
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004740 June 8, 2016 18 / 20
in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med
Parasitol. 1999; 93(4):367–77. PMID: 10656038
26. The Nordic Cochrane Centre. Review Manager Version 5.3. Copenhagen: The Cochrane Collabora-
tion; 2014.
27. Barclay J, Vestey J, Lambert A, Balmer C. Reducing the symptoms of lymphoedema: is there a role for
aromatherapy? Eur J Oncol Nurs. 2006; 10(2):140–9. PMID: 16563861
28. Jeffs E, Wiseman T. Randomised controlled trial to determine the benefit of daily home-based exercise
in addition to self-care in the management of breast cancer-related lymphoedema: a feasibility study.
Support Care Cancer. 2013; 21(4):1013–23. doi: 10.1007/s00520-012-1621-6 PMID: 23073712
29. Andersen L, Hojris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with
or without manual lymphatic drainage—a randomized study. Acta Oncol. 2000; 39(3):399–405. PMID:
10987238
30. Kerketta AS, Babu BV, Rath K, Jangid PK, Nayak AN, Kar SK. A randomized clinical trial to compare
the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lym-
phoedema. Tropical Medicine and International Health. 2005; 10(7):698–705. doi: 10.1111/j.1365-
3156.2005.01442.x PMID: 15960709
31. Letellier ME, Towers A, Shimony A, Tidhar D. Breast cancer-related lymphedema: a randomized con-
trolled pilot and feasibility study. Am J Phys Med Rehabil. 2014; 93(9):751–9; quiz 60–1. doi: 10.1097/
PHM.0000000000000089 PMID: 24743455
32. Mand S, Debrah AY, Klarmann U, Batsa L, Marfo-Debrekyei Y, Kwarteng A, et al. Doxycycline
improves filarial lymphedema independent of active filarial infection: A randomized controlled trial. Clini-
cal Infectious Diseases. 2012; 55(5):621–30. doi: 10.1093/cid/cis486 PMID: 22610930
33. Shenoy RK, Suma TK, Rajan K, Kumaraswami V. Prevention of acute adenolymphangitis in brugian fil-
ariasis: Comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local
treatment of the affected limb. Annals of Tropical Medicine and Parasitology. 1998; 92(5):587–94.
PMID: 9797832
34. Budge PJ, Little KM, Mues KE, Kennedy ED, Prakash A, Rout J, et al. Impact of Community-Based
Lymphedema Management on Perceived Disability among Patients with Lymphatic Filariasis in Orissa
State, India. PLOS Neglected Tropical Diseases. 2013; 7(3).
35. Mues KE, Deming M, Kleinbaum DG, Budge PJ, Klein M, Leon JS, et al. Impact of a Community-Based
Lymphedema Management Program on Episodes of Adenolymphangitis (ADLA) and Lymphedema
Progression—Odisha State, India. PLoS Negl Trop Dis. 2014; 8(9):e3140. doi: 10.1371/journal.pntd.
0003140 PMID: 25211334
36. Addiss DG, Louis-Charles J, Roberts J, Leconte F, Wendt JM, Milord MD, et al. Feasibility and effec-
tiveness of basic lymphedemamanagement in Leogane, Haiti, an area endemic for bancroftian filaria-
sis. PLoS Negl Trop Dis. 2010; 4(4):e668. doi: 10.1371/journal.pntd.0000668 PMID: 20422031
37. Bernhard L, Bernhard P, Magnussen P. Management of patients with lymphoedema caused by filaria-
sis in north-eastern Tanzania. Physiotherapy. 2003; 89(12):743–9.
38. Douglass J, Immink M, Piller N, Ullah S. Yoga for women with breast cancer-related lymphoedema: A
preliminary 6-month study. Journal of Lymphoedema. 2012; 7(2):30–8.
39. Wilson SF, Guarner J, Valme AL, Louis-Charles J, Jones TL, Addiss DG. Histopathologic improvement
with lymphedemamanagement, Leogane, Haiti. Emerg Infect Dis. 2004; 10(11):1938–46. PMID:
15550203
40. Jullien P, Some J, Brantus P, Bougma RW, Bamba I, Kyelem D. Efficacy of home-based lymphoedema
management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso. Acta Trop.
2011; 120 Suppl 1:S55–61. doi: 10.1016/j.actatropica.2011.03.007 PMID: 21470557
41. McPherson T. Impact on the quality of life of lymphoedema patients following introduction of a hygiene
and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical
intervention study. Filaria Journal [Internet]. 2003; 2. Available from: http://www.filariajournal.com/
content/2/1/1.
42. Gautam AP, Maiya AG, Vidyasagar MS. Effect of home-based exercise program on lymphedema and
quality of life in female postmastectomy patients: pre-post intervention study. J Rehabil Res Dev. 2011;
48(10):1261–8. PMID: 22234669
43. World Health Organization. Lymphatic Pathology and Immunology in Filariasis. Geneva: World Health
Organization; 1985.
44. World Health Organization. Informal Consultation on Evaluation of Morbidity in Lymphatic Filariasis,
Tuberculosis Research Centre, Madras, 10–11 February 1992 Geneva: WHO, 1992 Document WHO/
TDR/FIL/92.3
Self-Care for Management of Secondary Lymphedema: A Systematic Review
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004740 June 8, 2016 19 / 20
45. Beek MA, te Slaa A, van der Laan L, Mulder PG, Rutten HJ, Voogd AC, et al. Reliability of the Inverse
Water Volumetry Method to Measure the Volume of the Upper Limb. Lymphat Res Biol [Internet]. 2015
Jun; 13(2):[126–30 pp.]. Available from: http://online.liebertpub.com/doi/abs/10.1089/lrb.2015.0011?
url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed. doi: 10.1089/
lrb.2015.0011 PMID: 26091408
46. Moseley A, Piller N. Reliability of bioimpedance spectroscopy and tonometry after breast conserving
cancer treatment. Lymphat Res Biol. 2008; 6(2):85–7. doi: 10.1089/lrb.2008.1002 PMID: 18564923
47. Moseley A, Piller N, Carati C. Combined opto-electronic perometry and bioimpedance to measure
objectively the effectiveness of a new treatment intervention for chronic secondary leg lymphedema.
Lymphology. 2002; 35(4):136–43. PMID: 12570322
48. Das LK, Harichandrakumar KT, Vijayalakshmi G, De Britto LJ. Effect of domiciliary limb hygiene alone
on lymphoedema volume and locomotor function in filarial lymphoedema patients in Puducherry, India.
J Commun Dis. 2013; 45(1–2):17–23. PMID: 25141550
49. Mathieu E, Dorkenoo AM, Datagni M, Cantey PT, Morgah K, Harvey K, et al. It is possible: availability of
lymphedema case management in each health facility in Togo. Program description, evaluation, and
lessons learned. Am J Trop Med Hyg. 2013; 89(1):16–22. doi: 10.4269/ajtmh.12-0453 PMID:
23690550
50. Akogun OB, Badaki JA. Management of adenolymphangitis and lymphoedema due to lymphatic filaria-
sis in resource-limited North-eastern Nigeria. Acta Trop. 2011; 120 Suppl 1:S69–75. doi: 10.1016/j.
actatropica.2010.10.006 PMID: 20974106
51. Johansson K, Klernas P, Weibull A, Mattsson S. A home-based weight lifting program for patients with
arm lymphedema following breast cancer treatment: a pilot and feasibility study. Lymphology. 2014; 47
(2):51–64. PMID: 25282871
52. Jonsson C, Johansson K. The effects of pole walking on arm lymphedema and cardiovascular fitness
in women treated for breast cancer: a pilot and feasibility study. Physiother. 2014; 30(4):236–42. doi:
10.3109/09593985.2013.848961
53. Moseley AL, Piller NB, Carati CJ. The effect of gentle arm exercise and deep breathing on secondary
arm lymphedema. Lymphology. 2005; 38(3):136–45. PMID: 16353491
54. Koul R, Dufan T, Russell C, Guenther W, Nugent Z, Sun X, et al. Efficacy of complete decongestive
therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Interna-
tional Journal of Radiation Oncology Biology Physics. 2007; 67(3):841–6. doi: 10.1016/j.ijrobp.2006.
09.024
55. Suma TK, Shenoy RK, Kumaraswami V. Efficacy and sustainability of a footcare programme in pre-
venting acute attacks of adenolymphangitis in Brugian filariasis. Tropical Medicine and International
Health. 2002; 7(9):763–6. PMID: 12225507
56. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine
clinical use. Clin Exp Dermatol. 1994; 19(3):210–6. PMID: 8033378
57. World Health Organization. WHODAS II: Disability Assessment Schedule. Geneva, Switzerland:
World Health Organization; 2001.
58. Beaton DE,Wright JG, Katz JN. Development of the QuickDASH: Comparison of Three Item-Reduction
Approaches. The Journal of Bone & Amp; Joint Surgery. 2005; 87(5):1038–46.
59. Paterson C, Britten N. In pursuit of patient-centred outcomes: a qualitative evaluation of the 'Measure
Yourself Medical Outcome Profile'. Journal of health services research & policy. 2000; 5(1):27–36.
60. Stocks ME FM, Addiss DG,. The Effect of Hygiene-Based Lymphedema Management in Lymphatic Fil-
ariasis-Endemic Areas: A Systematic Review and Meta-analysis. PLoS Negl Trop Dis 2015; 9(10):
e0004171. doi: 10.1371/journal.pntd.0004171 PMID: 26496129
61. Eddy BA, Blackstock AJ, Williamson JM, Addiss DG, Streit TG, Beau de Rochars VM, et al. A longitudi-
nal analysis of the effect of mass drug administration on acute inflammatory episodes and disease pro-
gression in lymphedema patients in Leogane, Haiti. American Journal of Tropical Medicine & Hygiene.
2014; 90(1):80–8. http://dx.doi.org/10.4269/ajtmh.13-0317.
62. Ryan TJ, Narahari SR. Reporting an alliance using an integrative approach to the management of
lymphedema in India. International Journal of Lower Extremity Wounds. 2012; 11(1):5–9. doi: 10.1177/
1534734612438548 PMID: 22354118
Self-Care for Management of Secondary Lymphedema: A Systematic Review
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004740 June 8, 2016 20 / 20
